Immune Response To Mycobacterium Tuberculosis: A Narrative Review
Immune Response To Mycobacterium Tuberculosis: A Narrative Review
Immune Response To Mycobacterium Tuberculosis: A Narrative Review
The encounter between Mycobacterium tuberculosis (Mtb) and the host leads to
a complex and multifaceted immune response possibly resulting in latent infection,
tubercular disease or to the complete clearance of the pathogen. Macrophages and
CD4+ T lymphocytes, together with granuloma formation, are traditionally considered
the pillars of immune defense against Mtb and their role stands out clearly. However,
there is no component of the immune system that does not take part in the response to
this pathogen. On the other side, Mtb displays a complex artillery of immune-escaping
mechanisms capable of responding in an equally varied manner. In addition, the role of
each cellular line has become discussed and uncertain further than ever before. Each
defense mechanism is based on a subtle balance that, if altered, can lean to one side
to favor Mtb proliferation, resulting in disease progression and on the other to the host
tissue damage by the immune system itself. Through a brief and complete overview of
the role of each cell type involved in the Mtb response, we aimed to highlight the main
Edited by:
literature reviews and the most relevant studies in order to facilitate the approach to such
Gian Luigi Marseglia,
Policlinico San Matteo Fondazione a complex and changeable topic. In conclusion, this narrative mini-review summarizes
(IRCCS), Italy the various immunologic mechanisms which modulate the individual ability to fight Mtb
Reviewed by: infection taking in account the major host and pathogen determinants in the susceptibility
Silvia Garazzino,
University Hospital of the City of
to tuberculosis.
Health and Science of Turin, Italy Keywords: Mycobacterium tuberculosis, tuberculosis, children, immune response, immunity, macrophage,
Sara Manti, adaptive immunity, granuloma
University of Catania, Italy
*Correspondence:
Elena Chiappini INTRODUCTION
elena.chiappini@unifi.it
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) infection, was among the top
Specialty section: 10 causes of death worldwide in 2017 with about 1.5 million registered deceases (1). Mtb was
This article was submitted to responsible for approximately 10.0 million incident cases of TB disease with 10% of these occurring
Pediatric Immunology, among children (1). One to five bacilli may suffice to transmit the infection by air (2). When
a section of the journal
inhaled, Mtb encounters a first line of defense consisting of airway epithelial cells (AECs) and
Frontiers in Pediatrics
“professional” phagocytes (neutrophils, monocytes and dendritic cells) (3, 4). If this first line
Received: 07 April 2019 succeeds in eliminating the Mtb rapidly, the infection aborts (5). Otherwise, phagocytes are infected
Accepted: 06 August 2019
and the Mtb reproduces inside the cells, initially causing few, if any, clinical manifestations (5).
Published: 27 August 2019
The establishment of the infection, the development of active TB (ATB) rather than latent TB
Citation:
infection (LTBI) and the eventual evolution of LTBI to ATB depends on the complex relation
de Martino M, Lodi L, Galli L and
Chiappini E (2019) Immune Response
between bacterial and host factors.
to Mycobacterium tuberculosis: A The aim of this narrative minireview is to give a hint of the complexity of the above-
Narrative Review. mentioned determinants and to briefly summarize the major defense mechanisms of innate and
Front. Pediatr. 7:350. adaptive immunity against Mtb outlining the role of the different cell populations and their
doi: 10.3389/fped.2019.00350 complex interplay.
TABLE 1 | Key literature of the present review. latent infection phase. Mtb expresses an extremely wide variety of
virulence factors that counteract M8s efforts in suppressing the
Paragraph Topic Major references
pathogen. Among Mtb strategies we can include the inhibition
Host and bacterial Host Genetic - Harishankar et al. (10) of intracellular trafficking, the inhibition of autophagy, the
determinants in human polymorphism - Casanova and Abel (7) acquisition of cytosol access, the induction of host cell death and
tuberculosis - Cobat et al. (8) the neutralization of toxic components as reactive oxygen species
- Stein et al. (9)
and toxic metals (19).
- van Tong et al. (11)
MSMD - Rosain et al. (12)
Whilst IFN-γ is a key element in the containment of Mtb
Transcriptomic - Berry et al. (13) within the M8, it is now widely recognized that performing
studies - Blankley et al. (14) this function requires the presence of vitamin D (63). Thanks to
Bacterial - Forrellad et al. (15) vitamin D, the macrophage increases phagosome maturation and
Virulence factors the production of antimicrobial peptides through the maximal
Innate immune response AECs - Li et al. (16)
regulation of the hCAP-18 gene encoding for cathelicidin
against Mycobacterium - Harriff et al. (17)
tuberculosis
antimicrobial peptide which activates, in turn, the transcription
Macrophages - Queval et al. (18) of autophagy-related genes (20). The 6 kDa early secretory
- Lerner et al. (19) antigenic target (ESAT-6) protein family secretion (ESX) system
- Yuk et al. (20) is a sophisticated secretion system that Mtb uses to export
- Gröschel et al. (21)
proteins with immune-escaping activity. So that while the
- Bustamante et al. (22)
- Sia et al. (23)
IFN-γ axis is struggling against the ESX-system to enhance
- Sun et al. (24) phagolysosmal activity, vitamin D deficiency abets the Mtb
- Neyrolles et al. (25) replication (21).
- Botella et al. (26) Nitric oxide (NO) within macrophages plays a less important
Neutrophils - Kroon et al. (27)
role in humans than that one observed in animal models (19).
- Lowe et al. (28)
- Tan et al. (29)
Although, in humans too, reactive oxygen species (ROS) play
- Zhang et al. (30) a well-documented role in the immune response to Mtb as
Dendritic cells - Mihret (31) highlighted by the discovery of TB susceptibility in patients
- Khan et al. (32) displaying mutations in a catalytic subunit of NADPH-oxidase
- Wu et al. (33) 2 involved in ROS production on phagolysosomal membrane
- Balboa et al. (34)
- Georgieva et al. (35)
(22, 23). Moreover, it is demonstrated that Mtb affects NADPH-
- Velasquez et al. (36) oxidase activity through nucleoside diphosphate kinase (Npk)
- Ehlers (37) interaction with small GTPases involved in NADPH-oxidase
NK cells - Esin and Batoni (38) assembly and functioning (24).
- Arora et al. (39) The fight unfolds inside the phagosome of the M8 between
- Zhang et al. (40)
the cell and the Mtb with metals as a battlefield of sorts (25). The
Mast Cells - Garcia-Rodriguez et al. (41)
- Carlos et al. (42)
M8 delivers an overload of copper and zinc, which are toxic to
Complement - Lubbers et al. (43)
Mtb at high concentrations. Mtb deploys a series of protection
- Cai et al. (44) mechanisms that include controlling the capture of such metals,
Adaptive immune response CD4+ T - Cooper (45) oxidation, and an increase in efflux (25). The up-regulation of
against Mycobacterium lymphocytes - Sia et al. (46) ctpC gene encoding for the P-type ATPase which regulates the
tuberculosis - Domingo-Gonzalez et al. (47) intra-bacterial levels of Zinc is a clear example of how Mtb
- Parkash et al. (48)
- Sallin et al. (49)
manages to prevent heavy metal poisoning (26). As a counter-
CD8+ T - Lin and Flynn (50)
move, the M8 then attempts to block the arrival of nutrients to
lymphocytes - Canaday et al. (51) the Mtb such as iron and manganese (25).
- Oddo et al. (52)
Humoral - Kozakiewicz et al. (53) Neutrophils
immunity - Jacobs et al. (54) Neutrophil granulocytes are the most widely present cell
- Glatman-Freedman
and Casadevall (55)
population within BAL and sputum in patients with active TB
- Lu et al. (56) (27). There is evidence of their role as defense mechanisms
Granuloma - Ramakrishnan (57) against Mtb. In particular, there is a clear inverse correlation
- Russell (58) between the number of neutrophilic granulocytes in the
- Reece and Kaufmann (59) peripheral blood and the hazard of developing TB after
- Refai et al. (60)
contact with an infectious subject. Antimicrobial peptides and
- Martinot (61)
- Russell et al. (62) apoptotic neutrophils are phagocytized by M8 and carry out
an effective activity against Mtb inside these cells (28). This is
The major references are grouped basing on the different topics addressed in each
possible thanks to the fusion, within the M8, of neutrophil
paragraph. The most relevant and comprehensive review or study for each topic is
highlighted in bold. MSMD, Mendelian Susceptibility to Mycobacterial Disease; AEC, granules with phagosomes containing Mtb (29). Furthermore,
Airway Epithelial Cell; NK, Natural Killer cells. ETosis, extracellular traps (ET) formation, is a type of cell
death that differently from apoptosis is characterized by DNA the percentage representation of NK cell is augmented in the
release, consequent M8 activation and the formation of a peripheral blood of patients with ATB (65). There is a direct
DNA scaffold that incorporates pathogens and exposes them relationship between NK cell representation, clinical condition
to antimicrobial molecules (64). The formation of neutrophils and response to therapy (38, 65). Nonetheless, it has not yet been
ETs, thus constitutes an improved killing strategy and a synergic ascertained exactly what the cause and the consequence is (38).
alliance between phagocytes. Several components of the Mbt wall are recognized and bound
Moreover, as with many immune mechanisms, neutrophils by the NKp44 receptor of NK cells (39). In addition, Mtb-
do not only play a positive role, but can eventually constitute infected NKs lyse and stimulate M8s to produce IFN-γ and IL-
a negative element, causing tissue damage through production 22, which increase phagolysosomal fusion thus inhibiting Mtb
and subsequent release of their antimicrobial products (27). To replication and stimulate the production of additional IFN-γ by
this phenomenon, it must be added the potentially negative CD8+ lymphocytes. This effect is mediated by the IL-15 and IL-
interaction with lymphocytes. Neutrophils express on their cell 18 production by an infected M8. As a further infection control
membrane the ligand 1 of cell death (programmed death ligand mechanism DCs favor the development of T lymphocytes with
1 or PD-L1), which interacts with the lymphocyte receptor γδ receptor through TNF-α and IL-12 production (40).
for programmed death (programmed death receptor or PD-1),
and determines, in the course of chronic infections, the loss of
function and finally the death of lymphocytes (30).
Mast Cells
The role of mast cells in Mtb infection is not well-known
Neutrophils with expressed PD-L1 are present in high
in humans (41). In mice, mast cells capture Mtb via CD48
proportion in patients with ATB.
and internalize it. This process ensues the development of a
cytokine cascade, some of them with protective roles, including
Dendritic Cells IL-12, IL-13, IL-6, CXLL2, CCL7, CCL2, TNF-α, and consequent
DCs are functionally located in the middle between innate
neutrophils recall in the site of infection (41). Histamine’s
and adaptive immunity. These cells play a fundamental role in
role is ambivalent in terms of Mtb clearance as on one hand
the immune defense system due to antigen presentation, co-
it augments lung neutrophilia but on the other it seems
stimulating activity and the large cytokine production capacity
to impair the efficient production of a T helper 1 (Th1)
with activity on the lymphocytes cluster of differentiation (CD) 4
response (42). The presence of mast cell ETs containing Mtb
(32). DCs role in TB immunity is controversial. Present evidence
in humans has not been proved. However, mast cells enclose
is not sufficient to establish whether these cells strengthen
a large number of mediators known to take part in the
cellular immunity or if their manipulation by the Mtb can be
process (41).
used as a tool to diminish specific T-cell response (31). DCs
soon become a niche for the Mtb. CD209, also called DC-
specific intercellular adhesion molecule 3-grabbing non-integrin Complement Proteins
receptor (DC-SIGN), represents the gateway of Mtb into the The role of the complement cascade on the progression of the
DC (31). CD209 is, under normal conditions, a receptor for infection and Mtb disease is almost unknown (44). It is likely
CD54, the intercellular adhesion molecule 1 (ICAM1) present that the C5 and C7 components play a defensive role. However, it
on endothelial cells where it favors DCs migration. CD209 is has been observed that a high expression of C1q correlates with
coupled with the lipoarabinomannan mannose (ManLAM) of a worse clinical condition, so as to be a marker between latent
the Mtb that penetrates into the cell. This penetration leads to TB and active TB but still with unclear significance in terms of
a disruption of DCs activity by prompting the production of pathogenesis (43, 44).
interleukin (IL)-10 and reducing the production of IL-12, thus
causing a suppression of T lymphocytes activity (33, 34). The
manipulation of the maturation of the DCs probably represents ADAPTIVE IMMUNE RESPONSE AGAINST
one of the winning strategies of Mbt that, by restraining the Mycobacterium tuberculosis
activity of DCs and, consequently, of T lymphocytes, allows
the Mtb, whose speed of growth is relatively slow, to efficiently The immune response of T lymphocytes begins at the moment
establish a bridgehead in the airways (35). Based on the above that Mtb spreads inside the lymph nodes but its arousal lays
mentioned mechanism DC-SIGN has recently been proposed in the early activation of the innate immune system. Inside the
as a potential target for a vaccine purpose eventually able to lymph nodes, T lymphocytes undergo a process of activation
enhance immunity against Mtb (36). On the other side, DC- and expansion of the specific populations for the Mtb antigens.
SIGN may prevent tissue pathology by maintaining a balanced However, at this point, the largest part is done and the
inflammatory state and thus promoting host protection (37). infection is now established. Cellular immune response can be
evidenced 2–6 weeks after Mtb infection by the development
Natural Killer Cells of a delayed hypersensitivity response to intradermal injected
It is certain that NK cells enter the immunological circuit tuberculin (DHT) or purified protein derivative. It is important
of Mtb infection both in their CD56 diminished phenotype to underline that protective response to TB does not relate
(preferential cytotoxic activity) and in CD56 bright phenotype with DHT positivity and disease can occur in those who mount
(preferential cytokines secreting activity) (38). In several studies adequate DHT response (66) (Table 1).
IL-10 (60, 61, 70). As currently known, IL-6 and TNF-α favor NADPH-oxidase activity (31). With various mechanisms, some
inflammation, whilst IL-10 curbs it. Accordingly, the formation of which also operate at the level of macrophage DNA, the Mbt
of the granuloma is triggered by the M8 and then develops prevents the activation of pathogen destruction systems, which
with multi-nucleated giant cells and M8 with abundant presence are implemented through autophagy. The Mtb DNA manages to
of intracytoplasmic lipids, which lend these cells their frothy prevent the activation of the AIM2 inflammasome thus hindering
appearance. Around these cells, there is a ring of T lymphocytes the synthesis of IL-1β and IL-18 (31). Under normal conditions,
although B lymphocytes, neutrophils and dendritic cells (CD) IFN-γ stimulates the expression of MHC class II molecules
also participate in the formation of granuloma (4). on the M8. But Mtb, thanks to the prolonged activation of
Inside the granuloma, cholesterol—and not glucose or TLR2, succeeds in suppressing this mechanism. Even in cells that
glycerol—is the only carbon source. This leads to a lack of carbon already express class II MHC molecules, Mtb manages to block
and nutrients, hypoxia and a high concentration of nitric oxide the presentation of antigens by the action on ESCRT (endosomal
(NO). The significance of cholesterol in the survival of Mtb inside sorting complexes required for transport) of its EsxG·EsxH
the granuloma is evidenced by the negative role that statins play protein (31). The “great manipulator” also interferes with the
against Mtb (61, 70). functions of DCs, neutrophils and all other components of the
The debate remains open on whether the granuloma is purely immune system.
protective for the host or if it promotes disease progression In conclusion, having to deal with a micro-organism of great
and tissue damage (4). This uncertainty depends on the evasive abilities, immune mechanisms have only one way to go:
extreme heterogeneity detected in granuloma morphology at the to focus on a very rapid response at the onset of the infection.
different stages of disease, on the role of inflammation, hypoxia Paraphrasing a famous aphorism by General Erwin Rommel
and differential Mtb gene expression and lipid metabolism about amphibious battles that is well-suited to TB, victory
manipulation inside the granulomas of ATB and LTBI patients or defeat against Mtb is decided in the first moments
(62). The most likely answer is that an homeostatic interaction of the infection (5). Exactly as it happened on the first
establishes and the granuloma becomes a well-suited shelter for day of the amphibious assault, the day that General Erwin
both Mtb long-term survival and host protection (57). Rommel defined as “the longest day.” When it comes to
implementing new prevention and therapeutic approaches, a
clear understanding of the interplay between the immune system
DISCUSSION
and Mtb at a molecular level is the only way to unravel this
Mycobacterium tuberculosis: The Great millenary skein.
Manipulator
The different cell lines of innate and adaptive immunity come AUTHOR CONTRIBUTIONS
into play at different times in the battle against Mtb in a clash
in which the genetic susceptibility of the host and the virulence MdM wrote the main body of this minireview. LL, LG, and EC
of the pathogen play decisive roles for the final outcome. The contributed with literature search and revisions.
success of Mtb over thousands of years against man arises
from its extraordinary ability to subvert the mechanisms that FUNDING
should eliminate it in the M8 from the infection onset. At the
onset of the infection, Mtb manages to perforate the phagosome This work received no fundings. The payment of fees for open
in the M8 through the ESX system and, therefore, to block access publication will be supported by the Dipartimento di
its maturation via Npk, which inhibits lysosomal traffic and Medicina Sperimentale e Clinica of the University of Florence.
11. van Tong H, Velavan TP, Thye T, Meyer CG. Human genetic factors 31. Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection.
in tuberculosis: an update. Trop Med Int Health. (2017) 22:1063–71. Virulence. (2012) 3:654–9. doi: 10.4161/viru.22586
doi: 10.1111/tmi.12923 32. Khan N, Vidyarthi A, Pahari S, Agrewala JN. Distinct strategies employed
12. Rosain J, Kong X-F, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo by dendritic cells and macrophages in restricting Mycobacterium tuberculosis
N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014– infection: different philosophies but same desire. Int Rev Immunol.
2018 update. Immunol Cell Biol. (2019) 97:360–7. doi: 10.1111/imcb.12210 (2016) 35:386–98. doi: 10.3109/08830185.2015.1015718
13. Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SAA, Oni T, et al. 33. Wu T, Guo S, Wang J, Li L, Xu L, Liu P, et al. Interaction between
An interferon-inducible neutrophil-driven blood transcriptional signature in mannosylated lipoarabinomannan and dendritic cell-specific intercellular
human tuberculosis. Nature. (2010) 466:973–7. doi: 10.1038/nature09247 adhesion molecule-3 grabbing nonintegrin influences dendritic cells
14. Blankley S, Graham CM, Turner J, Berry MPR, Bloom CI, Xu Z, et al. maturation and T cell immunity. Cell Immunol. (2011) 272:94–101.
The transcriptional signature of active tuberculosis reflects symptom doi: 10.1016/j.cellimm.2011.09.001
status in extra-pulmonary and pulmonary tuberculosis. PLoS ONE. 34. Balboa L, Romero MM, Yokobori N, Schierloh P, Geffner L, Basile JI,
(2016) 11:e0162220. doi: 10.1371/journal.pone.0162220 et al. Mycobacterium tuberculosis impairs dendritic cell response by altering
15. Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni HR, CD1b, DC-SIGN and MR profile. Immunol Cell Biol. (2010) 88:716–26.
Santangelo M de la P, et al. Virulence factors of the Mycobacterium tuberculosis doi: 10.1038/icb.2010.22
complex. Virulence. (2013) 4:3–66. doi: 10.4161/viru.22329 35. Georgieva M, Sia JK, Bizzell E, Madan-Lala R, Rengarajan J. Mycobacterium
16. Li Y, Wang Y, Liu X. The role of airway epithelial cells in response tuberculosis GroEL2 modulates dendritic cell responses. Infect Immun.
to mycobacteria infection. Clin Dev Immunol. (2012) 2012:791392. (2018) 86:e00387-17. doi: 10.1128/IAI.00387-17
doi: 10.1155/2012/791392 36. Velasquez LN, Stüve P, Gentilini MV, Swallow M, Bartel J, Lycke
17. Harriff MJ, Cansler ME, Toren KG, Canfield ET, Kwak S, Gold MC, et al. NY, et al. Targeting Mycobacterium tuberculosis antigens to dendritic
Human lung epithelial cells contain Mycobacterium tuberculosis in a late cells via the DC-specific-ICAM3-grabbing-nonintegrin receptor induces
endosomal vacuole and are efficiently recognized by CD8+ T cells. PLoS ONE. strong T-helper 1 immune responses. Front Immunol. (2018) 9:471.
(2014) 9:e97515. doi: 10.1371/journal.pone.0097515 doi: 10.3389/fimmu.2018.00471
18. Queval CJ, Brosch R, Simeone R. The macrophage: a disputed fortress in 37. Ehlers S. DC-SIGN and mannosylated surface structures of Mycobacterium
the battle against Mycobacterium tuberculosis. Front Microbiol. (2017) 8:2284. tuberculosis: a deceptive liaison. Eur J Cell Biol. (2010) 89:95–101.
doi: 10.3389/fmicb.2017.02284 doi: 10.1016/j.ejcb.2009.10.004
19. Lerner TR, Borel S, Gutierrez MG. The innate immune response in human 38. Esin S, Batoni G. Natural killer cells: a coherent model for their functional
tuberculosis. Cell Microbiol. (2015) 17:1277–85. doi: 10.1111/cmi.12480 role in Mycobacterium tuberculosis infection. J Innate Immun. (2015) 7:11–24.
20. Yuk J-M, Shin D-M, Lee H-M, Yang C-S, Jin HS, Kim K-K, et al. Vitamin D3 doi: 10.1159/000363321
induces autophagy in human monocytes/macrophages via cathelicidin. Cell 39. Arora P, Foster EL, Porcelli SA. CD1d and natural killer T cells in immunity
Host Microbe. (2009) 6:231–43. doi: 10.1016/j.chom.2009.08.004 to Mycobacterium tuberculosis. Adv Exp Med Biol. (2013) 783:199–223.
21. Gröschel MI, Sayes F, Simeone R, Majlessi L, Brosch R. ESX secretion systems: doi: 10.1007/978-1-4614-6111-1_11
mycobacterial evolution to counter host immunity. Nat Rev Microbiol. 40. Zhang R, Zheng X, Li B, Wei H, Tian Z. Human NK cells positively regulate
(2016) 14:677–91. doi: 10.1038/nrmicro.2016.131 gammadelta T cells in response to Mycobacterium tuberculosis. J Immunol.
22. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. (2006) 176:2610–6. doi: 10.4049/jimmunol.176.4.2610
Germline CYBB mutations that selectively affect macrophages in kindreds 41. Garcia-Rodriguez KM, Goenka A, Alonso-Rasgado MT, Hernández-
with X-linked predisposition to tuberculous mycobacterial disease. Nat Pando R, Bulfone-Paus S. The role of mast cells in tuberculosis:
Immunol. (2011) 12:213–21. doi: 10.1038/ni.1992 orchestrating innate immune crosstalk? Front Immunol. (2017) 8:1290.
23. Sia JK, Georgieva M, Rengarajan J. Innate immune defenses in human doi: 10.3389/fimmu.2017.01290
tuberculosis: an overview of the interactions between Mycobacterium 42. Carlos D, Fremond C, Samarina A, Vasseur V, Maillet I, Ramos SG,
tuberculosis and innate immune cells. J Immunol Res. (2015) 2015:747543. et al. Histamine plays an essential regulatory role in lung inflammation
doi: 10.1155/2015/747543 and protective immunity in the acute phase of Mycobacterium
24. Sun J, Singh V, Lau A, Stokes RW, Obregón-Henao A, Orme IM, tuberculosis infection. Infect Immun. (2009) 77:5359–68. doi: 10.1128/IAI.
et al. Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates 01497-08
small GTPases leading to evasion of innate immunity. PLoS Pathog. 43. Lubbers R, Sutherland JS, Goletti D, de Paus RA, van Moorsel CHM, Veltkamp
(2013) 9:e1003499. doi: 10.1371/journal.ppat.1003499 M, et al. Complement component C1q as serum biomarker to detect active
25. Neyrolles O, Wolschendorf F, Mitra A, Niederweis M. Mycobacteria, tuberculosis. Front Immunol. (2018) 9:2427. doi: 10.3389/fimmu.2018.02427
metals, and the macrophage. Immunol Rev. (2015) 264:249–63. 44. Cai Y, Yang Q, Tang Y, Zhang M, Liu H, Zhang G, et al. Increased
doi: 10.1111/imr.12265 complement C1q level marks active disease in human tuberculosis. PLoS ONE.
26. Botella H, Peyron P, Levillain F, Poincloux R, Poquet Y, Brandli (2014) 9:e92340. doi: 10.1371/journal.pone.0092340
I, et al. Mycobacterial p(1)-type ATPases mediate resistance to zinc 45. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev
poisoning in human macrophages. Cell Host Microbe. (2011) 10:248–59. Immunol. (2009) 27:393–422. doi: 10.1146/annurev.immunol.021908.132703
doi: 10.1016/j.chom.2011.08.006 46. Sia JK, Bizzell E, Madan-Lala R, Rengarajan J. Engaging the CD40-
27. Kroon EE, Coussens AK, Kinnear C, Orlova M, Möller M, Seeger A, CD40L pathway augments T-helper cell responses and improves control
et al. Neutrophils: innate effectors of TB resistance? Front Immunol. of Mycobacterium tuberculosis infection. PLoS Pathog. (2017) 13:e1006530.
(2018) 9:2637.doi: 10.3389/fimmu.2018.02637 doi: 10.1371/journal.ppat.1006530
28. Lowe DM, Demaret J, Bangani N, Nakiwala JK, Goliath R, Wilkinson KA, 47. Domingo-Gonzalez R, Prince O, Cooper A, Khader SA. Cytokines and
et al. Differential effect of viable versus necrotic neutrophils on Mycobacterium chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr.
tuberculosis growth and cytokine induction in whole blood. Front Immunol. (2016) 4:TBTB2-0018-2016. doi: 10.1128/microbiolspec.TBTB2-0018-2016
(2018) 9:903. doi: 10.3389/fimmu.2018.00903 48. Parkash O, Agrawal S, Madhan Kumar M. T regulatory cells: Achilles’ heel
29. Tan BH, Meinken C, Bastian M, Bruns H, Legaspi A, Ochoa MT, of Mycobacterium tuberculosis infection? Immunol Res. (2015) 62:386–98.
et al. Macrophages acquire neutrophil granules for antimicrobial doi: 10.1007/s12026-015-8654-0
activity against intracellular pathogens. J Immunol. (2006) 177:1864–71. 49. Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, Barber DL.
doi: 10.4049/jimmunol.177.3.1864 Th1 differentiation drives the accumulation of intravascular, non-
30. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, et al. PD-L1 protective CD4 T cells during tuberculosis. Cell Rep. (2017) 18:3091–104.
blockade improves survival in experimental sepsis by inhibiting doi: 10.1016/j.celrep.2017.03.007
lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 50. Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin
(2010) 14:R220.doi: 10.1186/cc9354 Immunopathol. (2015) 37:239–49. doi: 10.1007/s00281-015-0490-8
51. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4+ 64. Guimarães-Costa AB, Nascimento MTC, Wardini AB, Pinto-da-
and CD8+ T cells kill intracellular Mycobacterium tuberculosis by a perforin Silva LH, Saraiva EM. ETosis: a microbicidal mechanism beyond
and Fas/Fas ligand-independent mechanism. J Immunol. (2001) 167:2734–42. cell death. J Parasitol Res. (2012) 2012:929743. doi: 10.1155/2012/9
doi: 10.4049/jimmunol.167.5.2734 29743
52. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. 65. Venturini E, Lodi L, Francolino I, Ricci S, Chiappini E, de Martino M,
Fas ligand-induced apoptosis of infected human macrophages reduces et al. CD3, CD4, CD8, CD19 and CD16/CD56 positive cells in tuberculosis
the viability of intracellular Mycobacterium tuberculosis. J Immunol. infection and disease: peculiar features in children. Int J Immunopathol
(1998) 160:5448–54. Pharmacol. (2019) 33:2058738419840241. doi: 10.1177/2058738419
53. Kozakiewicz L, Phuah J, Flynn J, Chan J. The role of B cells and humoral 840241
immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol. 66. McKinney J, Jacobs W, Bloom B. Persisting problems in tuberculosis.
(2013) 783:225–50. doi: 10.1007/978-1-4614-6111-1_12 In: Krause RM, editor. Emerging Infections. San Diego, CA: Academic
54. Jacobs AJ, Mongkolsapaya J, Screaton GR, McShane H, Wilkinson Press (1998). p. 51–146.
RJ. Antibodies and tuberculosis. Tuberculosis. (2016) 101:102–3. 67. Monin L, Griffiths KL, Slight S, Lin Y, Rangel-Moreno J, Khader
doi: 10.1016/j.tube.2016.08.001 SA. Immune requirements for protective Th17 recall responses to
55. Glatman-Freedman A, Casadevall A. Serum therapy for tuberculosis revisited: Mycobacterium tuberculosis challenge. Mucosal Immunol. (2015) 8:1099–109.
reappraisal of the role of antibody-mediated immunity against Mycobacterium doi: 10.1038/mi.2014.136
tuberculosis. Clin Microbiol Rev. (1998) 11:514–32. 68. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice
56. Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS, et al. deficient in CD4 T cells have only transiently diminished levels of IFN-
A functional role for antibodies in tuberculosis. Cell. (2016) 167:433-443.e14. gamma, yet succumb to tuberculosis. J Immunol. (1999) 162:5407–16.
doi: 10.1016/j.cell.2016.08.072 69. Wayne LG. Dynamics of submerged growth of Mycobacterium tuberculosis
57. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev under aerobic and microaerophilic conditions. Am Rev Respir Dis.
Immunol. (2012) 12:352–66. doi: 10.1038/nri3211 (1976) 114:807–11.
58. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol. 70. Gibson SER, Harrison J, Cox JAG. Modelling a silent epidemic: a review
(2007) 5:39–47. doi: 10.1038/nrmicro1538 of the in vitro models of latent tuberculosis. Pathogens. (2018) 7:E88.
59. Reece ST, Kaufmann SHE. Floating between the poles of pathology and doi: 10.3390/pathogens7040088
protection: can we pin down the granuloma in tuberculosis? Curr Opin
Microbiol. (2012) 15:63–70. doi: 10.1016/j.mib.2011.10.006 Conflict of Interest Statement: The authors declare that the research was
60. Refai A, Gritli S, Barbouche M-R, Essafi M. Mycobacterium tuberculosis conducted in the absence of any commercial or financial relationships that could
virulent factor ESAT-6 drives macrophage differentiation toward the pro- be construed as a potential conflict of interest.
inflammatory M1 phenotype and subsequently switches it to the anti-
inflammatory M2 phenotype. Front Cell Infect Microbiol. (2018) 8:327. The handling editor declared a past co-authorship with several of the authors
doi: 10.3389/fcimb.2018.00327 MdM, LG, and EC.
61. Martinot AJ. Microbial offense vs host defense: who controls the TB
granuloma? Vet Pathol. (2018) 55:14–26. doi: 10.1177/0300985817705177 Copyright © 2019 de Martino, Lodi, Galli and Chiappini. This is an open-access
62. Russell DG, Cardona P-J, Kim M-J, Allain S, Altare F. Foamy macrophages article distributed under the terms of the Creative Commons Attribution License (CC
and the progression of the human tuberculosis granuloma. Nat Immunol. BY). The use, distribution or reproduction in other forums is permitted, provided
(2009) 10:943–8. the original author(s) and the copyright owner(s) are credited and that the original
63. Gou X, Pan L, Tang F, Gao H, Xiao D. The association between publication in this journal is cited, in accordance with accepted academic practice.
vitamin D status and tuberculosis in children: a meta-analysis. Medicine. No use, distribution or reproduction is permitted which does not comply with these
(2018) 97:e12179. doi: 10.1097/MD.0000000000012179 terms.